🔴 Relay Therapeutics Inc is trading 4.1% down today on dilution concerns and a broader biotech sell-off

Relay Therapeutics Inc is trading 4.1% down at $13.52 today as dilution concerns and a risk-off environment for biotech names weigh on the stock.

• The stock is giving back a portion of last week’s sharp rally as growth and biotech sectors face pressure in a weak, inflation-hit market.
• Investors remain focused on dilution risks following a May 2026 follow-on offering of 22.9 million shares and a June 2026 move to increase authorized common stock to 450 million shares.